Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Hyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner.

Popovic ZV, Embgenbroich M, Chessa F, Nordström V, Bonrouhi M, Hielscher T, Gretz N, Wang S, Mathow D, Quast T, Schloetel JG, Kolanus W, Burgdorf S, Gröne HJ.

Sci Rep. 2017 Mar 22;7(1):311. doi: 10.1038/s41598-017-00434-y.

2.

Deficiency of N-myristoylation reveals calcineurin activity as regulator of IFN-γ-producing γδ T cells.

Rampoldi F, Brunk F, Bonrouhi M, Federico G, Krunic D, Porubsky S, Gröne HJ, Popovic ZV.

J Leukoc Biol. 2017 Apr;101(4):1005-1014. doi: 10.1189/jlb.1A0616-264R. Epub 2017 Jan 6.

PMID:
28062573
3.

Immunosuppression and Aberrant T Cell Development in the Absence of N-Myristoylation.

Rampoldi F, Bonrouhi M, Boehm ME, Lehmann WD, Popovic ZV, Kaden S, Federico G, Brunk F, Gröne HJ, Porubsky S.

J Immunol. 2015 Nov 1;195(9):4228-43. doi: 10.4049/jimmunol.1500622. Epub 2015 Sep 30.

4.

Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors.

Kiss E, Kränzlin B, Wagenblaβ K, Bonrouhi M, Thiery J, Gröne E, Nordström V, Teupser D, Gretz N, Malle E, Gröne HJ.

Am J Pathol. 2013 Mar;182(3):727-41. doi: 10.1016/j.ajpath.2012.11.033. Epub 2013 Jan 12.

PMID:
23318573
5.

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.

Porubsky S, Speak AO, Salio M, Jennemann R, Bonrouhi M, Zafarulla R, Singh Y, Dyson J, Luckow B, Lehuen A, Malle E, Müthing J, Platt FM, Cerundolo V, Gröne HJ.

J Immunol. 2012 Sep 15;189(6):3007-17. doi: 10.4049/jimmunol.1201483. Epub 2012 Aug 8.

6.

The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis.

Popovic ZV, Wang S, Papatriantafyllou M, Kaya Z, Porubsky S, Meisner M, Bonrouhi M, Burgdorf S, Young MF, Schaefer L, Gröne HJ.

J Immunol. 2011 Dec 15;187(12):6217-26. doi: 10.4049/jimmunol.1003478. Epub 2011 Nov 16.

7.

Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.

Kiss E, Popovic Z, Bedke J, Wang S, Bonrouhi M, Gretz N, Stettner P, Teupser D, Thiery J, Porubsky S, Adams J, Gröne HJ.

Am J Pathol. 2011 Jul;179(1):92-103. doi: 10.1016/j.ajpath.2011.03.019. Epub 2011 May 5.

8.

Rhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection.

Porubsky S, Wang S, Kiss E, Dehmel S, Bonrouhi M, Dorn T, Luckow B, Brakebusch C, Gröne HJ.

Eur J Immunol. 2011 Jan;41(1):76-88. doi: 10.1002/eji.201040420. Epub 2010 Nov 11.

9.

Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage.

Kiss E, Popovic ZV, Bedke J, Adams J, Bonrouhi M, Babelova A, Schmidt C, Edenhofer F, Zschiedrich I, Domhan S, Abdollahi A, Schäfer L, Gretz N, Porubsky S, Gröne HJ.

Am J Pathol. 2010 May;176(5):2150-62. doi: 10.2353/ajpath.2010.090370. Epub 2010 Apr 2.

10.

Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.

Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, Gretz N, Schaefer L, Kirschning CJ, Popovic ZV, Gröne HJ.

Dis Model Mech. 2010 Jan-Feb;3(1-2):92-103. doi: 10.1242/dmm.003533. Epub 2009 Dec 28.

11.

[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].

Porubsky S, Luckow B, Bonrouhi M, Speak A, Cerundolo V, Platt F, Gröne HJ.

Pathologe. 2008 Nov;29 Suppl 2:297-302. doi: 10.1007/s00292-008-1040-0. German.

PMID:
18810447
12.

Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage.

Bedke J, Kiss E, Schaefer L, Behnes CL, Bonrouhi M, Gretz N, Horuk R, Diedrichs-Moehring M, Wildner G, Nelson PJ, Gröne HJ.

Am J Transplant. 2007 Mar;7(3):527-37. Epub 2007 Jan 4.

13.

Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.

Jennemann R, Sandhoff R, Wang S, Kiss E, Gretz N, Zuliani C, Martin-Villalba A, Jäger R, Schorle H, Kenzelmann M, Bonrouhi M, Wiegandt H, Gröne HJ.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12459-64. Epub 2005 Aug 18.

14.

13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.

Adams J, Kiss E, Arroyo AB, Bonrouhi M, Sun Q, Li Z, Gretz N, Schnitger A, Zouboulis CC, Wiesel M, Wagner J, Nelson PJ, Gröne HJ.

Am J Pathol. 2005 Jul;167(1):285-98.

15.

Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.

Porubsky S, Schmid H, Bonrouhi M, Kretzler M, Malle E, Nelson PJ, Gröne HJ.

Am J Pathol. 2004 Jun;164(6):2175-87.

16.

High-accuracy amplification of nanogram total RNA amounts for gene profiling.

Kenzelmann M, Klären R, Hergenhahn M, Bonrouhi M, Gröne HJ, Schmid W, Schütz G.

Genomics. 2004 Apr;83(4):550-8.

PMID:
15028277
17.

Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression.

Henger A, Kretzler M, Doran P, Bonrouhi M, Schmid H, Kiss E, Cohen CD, Madden S, Porubsky S, Gröne EF, Schlöndorff D, Nelson PJ, Gröne HJ.

Kidney Int. 2004 Mar;65(3):904-17.

18.

Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.

Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klären R, Gröne EF, Wiesel M, Güdemann C, Küster J, Schott W, Staehler G, Kretzler M, Hollstein M, Gröne HJ.

Am J Pathol. 2002 Jun;160(6):2169-80.

Supplemental Content

Loading ...
Support Center